Willow Bioscience Announces 3 Million Dollar Fundraising to Support Partnership With Laurus Labs | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 7 08:19 ET

Willow Biosciences to Launch a $3m Brokered Placement | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsJun 3 03:59 ET

Press Release: WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Canada NewsWire SUNNYVALE, Calif., May 13, 2024 Company continues to advance its corticosteroid product

Dow JonesMay 13 07:00 ET

Willow Biosciences Anticipating Large Strategic Partnership | TSX:WLLW, OTCQB:CANSF

Proactive InvestorsMay 13 04:49 ET

Willow Biosciences Narrows 2023 Loss YOY

Willow Biosciences Inc. (WLLW.TO) over the long weekend reported a 2023 net comprehensive loss of $13.1 million, or loss of $0.10 per basic and diluted share, narrowing from a loss of $14.8 million, o

MT NewswiresApr 1 07:38 ET

Press Release: WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF Canada NewsWire SUNNYVALE, Calif., March 28, 2024 Completed the reorganization of

Dow JonesMar 28 19:30 ET